We are live on ! Find out more
ICUI icon

ICU Medical

277 hedge funds and large institutions have $4.17B invested in ICU Medical in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 91 increasing their positions, 96 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

669% more call options, than puts

Call options by funds: $23.7M | Put options by funds: $3.09M

1% more capital invested

Capital invested by funds: $4.12B → $4.17B (+$52.5M)

0.68% more ownership

Funds ownership: 95%95.68% (+0.68%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

5% less repeat investments, than reductions

Existing positions increased: 91 | Existing positions reduced: 96

4% less funds holding

Funds holding: 288277 (-11)

32% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 34

Holders
277
Holders Change
-11
Holders Change %
-3.82%
% of All Funds
4.82%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
23
Increased
91
Reduced
96
Closed
34
Calls
$23.7M
Puts
$3.09M
Net Calls
+$20.6M
Net Calls Change
+$818K
Name Holding Trade Value Shares
Change
Change in
Stake
New York State Common Retirement Fund
76
New York State Common Retirement Fund
New York
$4.76M
CS
77
Credit Suisse
Switzerland
$4.72M -$981K -4,769 -17%
Point72 Asset Management
78
Point72 Asset Management
Connecticut
$4.7M -$32.9M -159,787 -88%
KMC
79
Kirr Marbach & Co
Indiana
$4.66M +$71.4K +347 +2%
ER
80
EVR Research
Virginia
$4.53M
Manulife (Manufacturers Life Insurance)
81
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.45M -$92.2K -448 -2%
Holocene Advisors
82
Holocene Advisors
New York
$4.4M -$144K -699 -3%
BA
83
Bridgewater Associates
Connecticut
$4.39M +$4.38M +21,312 New
JAM
84
Jupiter Asset Management
United Kingdom
$4.33M
SFI
85
Susquehanna Fundamental Investments
Pennsylvania
$4.16M +$2.52M +12,256 +154%
Ensign Peak Advisors
86
Ensign Peak Advisors
Utah
$3.84M +$640K +3,110 +20%
SIA
87
Sit Investment Associates
Minnesota
$3.82M
MOACM
88
Mutual of America Capital Management
New York
$3.57M -$83.9K -408 -2%
Man Group
89
Man Group
United Kingdom
$3.29M +$1.28M +6,246 +64%
AB
90
Amalgamated Bank
New York
$3.2M +$2.63M +12,770 +457%
UBS Group
91
UBS Group
Switzerland
$3.06M +$678K +3,298 +28%
Two Sigma Advisers
92
Two Sigma Advisers
New York
$3.05M -$535K -2,600 -15%
TPSF
93
Texas Permanent School Fund
Texas
$3.03M +$3.91K +19 +0.1%
CI
94
Cambiar Investors
Colorado
$2.98M +$270K +1,314 +10%
Mariner
95
Mariner
Kansas
$2.77M +$2.76M +13,437 New
State of New Jersey Common Pension Fund D
96
State of New Jersey Common Pension Fund D
New Jersey
$2.55M +$2.55M +12,394 New
Thrivent Financial for Lutherans
97
Thrivent Financial for Lutherans
Minnesota
$2.3M +$1.14M +5,549 +99%
State of Tennessee, Department of Treasury
98
State of Tennessee, Department of Treasury
Tennessee
$2.13M
Comerica Bank
99
Comerica Bank
Texas
$2.11M -$55.5K -270 -2%
MIM
100
MetLife Investment Management
New Jersey
$2.03M -$60.5K -294 -3%

ICUI Hedge Fund Activity: Q2 2021 in Review

277 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in ICU Medical (ICUI) for Q2 2021, worth a combined $4.17B — up 1.3% from $4.12B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of ICUI and 23 opened new positions — a net loss of 11 holders — while 96 trimmed existing stakes and 91 added.

The largest buyer was Nuance Investments, adding an estimated $67.1M. The largest seller was T. Rowe Price Associates, cutting an estimated $41.4M.

  • 277 institutional investors held ICU Medical (ICUI) as of Q2 2021, down from 288 in Q1 2021.
  • Funds reported $4.17B of ICU Medical stock for Q2 2021, up 1.3% quarter-over-quarter.
  • 23 funds opened new ICU Medical positions in Q2 2021 and 34 closed out, a net change of -11 holders.
  • The largest ICU Medical buyer in Q2 2021 was Nuance Investments, an estimated $67.1M added.
  • The largest ICU Medical seller in Q2 2021 was T. Rowe Price Associates, an estimated $41.4M sold.

Based on aggregated 13F filings for Q2 2021.